You are here: Industry Insights > Acquisition

News List

Sanofi concludes acquisition of Principia Biopharma expresspharma
October 09, 2020
The Principia acquisition strengthens Sanofi’s core areas of autoimmune and allergic diseases.
Permira to acquire German pharma firm Neuraxpharm pharmaceutical-technology
September 27, 2020
Private equity firm Permira has agreed to acquire German speciality pharmaceutical company Neuraxpharm from Apax Partners.
Viva Biotech and SYNthesis Enter Strategic Acquisition Agreement contractpharma
September 22, 2020
Accelerates Viva’s development of global innovative drug R&D service capabilities.
Gilead agrees to acquire Immunomedics for $21bn pharmaceutical-technology
September 15, 2020
Gilead Sciences has signed a definitive agreement to acquire cancer therapies developer Immunomedics for a total consideration of approximately $21bn, or $88 per share.
ILC Dover Acquires Solo Containment contractpharma
September 15, 2020
UK-based provider of products used in pharmaceutical and biopharmaceutical manufacturing.
Nutriband Acquires Transdermal and Health Product Manufacturing Business contractpharma
September 03, 2020
Nutriband Inc., a Nevada Corporation, has completed the acquisition of Pocono Coated Product's Transdermal and Health product manufacturing business, effective August 31, 2020.
Ionis to Acquire Outstanding Shares of Akcea for $500M contractpharma
September 01, 2020
Ionis will benefit from Akcea's pipeline and commercial products, and further strengthens financial position to support future investments.
GI Partners Acquires Clinical Ink contractpharma
August 28, 2020
Plans to accelerate Clinical Ink’s innovation in clinical trial workflow solutions.
DWK Life Sciences acquires Müller + Müller expresspharma
August 28, 2020
Müller + Müller will be managed by CEO Florian Müller-Stauch.
Acadia buys clinical-stage biotechnology company CerSci Therapeutics pharmaceutical-business-review
August 27, 2020
Acadia Pharmaceuticals has added novel pain programme to its portfolio with the acquisition of clinical-stage biotechnology company CerSci Therapeutics.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page